Delve Detect Enables Neurologists to Treat CNS Infections When Conventional Testing Fails Delve Bio, a UCSF spin-out and pioneer in metagenomic next-generation sequencing (mNGS) for infectious diseases, announced data underscoring the clinical impact of mNGS using Delve Detect to identify pathogens and…
Forlong Biotechnology Announced CMC Readiness to Initiate GMP Batch Production to Support Upcoming Pivotal Clinical Trial for FL115 (IL-15 Superagonist) in Nonmuscle Invasive Bladder Cancer (NMIBC) Forlong Biotechnology, a clinical-stage biotech company focusing on developing transformative cytokine therapies for patients…
NorthStar Secures FDA Acceptance of Drug Master File for No-Carrier-Added Actinium-225 NorthStar Medical Radioisotopes, LLC a leading radiopharmaceutical company, today announced that it received notice of the U.S. Food & Drug Administration’s (FDA) acceptance of its Type II Drug Master…
AMGTA Releases Independent Report on Additive Manufacturing’s Role in Resource-Efficient Manufacturing Systems Following its 2026 Annual Member Summit, AMGTA released Additive Manufacturing in Resource-Efficient Manufacturing Systems, an independent report establishing how additive manufacturing should be evaluated, communicated, and deployed across part,…
Organon’s VTAMA® (tapinarof) cream, 1%, Granted Strong Recommendation in the 2026 American Academy of Dermatology Guidelines for Pediatric Atopic Dermatitis Organon a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day, today announced…
Precision BioSciences Expands ELIMINATE-B Trial Following Clinical Trial Application Approval in Two European Countries Precision BioSciences, Inc. a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases, today announced…
VectorBuilder Introduces High-Stability MuteFree™ AAV to Improve Gene Therapy Manufacturing Reliability VectorBuilder, a global leader in gene delivery technologies and CDMO solutions, announced MuteFree™ AAV, a high-stability AAV vector designed to address ITR instability, a common challenge in gene therapy…
Switch Automation and Berkeley Lab Advance Next Generation of Smart Buildings—From Analytics to Autonomous Operations Switch Automation, a global provider of smart building software, today announced the release of new product capabilities in Switch OpX (Operational Excellence), developed in collaboration…
Nick Dokoozlian Named Recipient of Triple Helix AgTech Leadership Prize Triple Helix Institute for Agriculture, Climate, and Society a nonprofit dedicated to building cross-sector engagement and public understanding around agriculture technology (AgTech), today announced Dr. Nick Dokoozlian as the recipient…
Valo Health Appoints Chris Anagnostopoulos, PhD, as Chief Causal AI Officer Valo Health, Inc. a pioneer in the use of human data and AI to accelerate drug discovery and development, announced the appointment of Chris Anagnostopoulos, PhD, C.Stat, to the…
Compass Pathways Announces U.S Grant Program for the Creation of Post-Approval COMP360 Provider Training Compass Pathways plc a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced an invitation for U.S. based organizations to apply…
Quiver Bioscience Receives Strategic Investment From the Porta Family to Advance UBE3A ASO Therapeutic Program for Dup15q Syndrome Quiver Bioscience a discovery technology and therapeutics company advancing programs for the treatment of serious central nervous system (CNS) disorders, today announced…